补肾抗衰颗粒对老年人保护作用的转录组学与代谢组学研究
本研究采用自身对照设计结合RNA-seq与代谢组学,评价补肾抗衰颗粒(BKG)对老年人衰老相关症状的疗效与安全性,并以D-半乳糖诱导的AC16细胞模型进行体外验证。结果显示BKG可显著改善中医衰老症状、降低SOD水平及TNF-α水平,并逆转多种衰老相关基因与代谢物表达,其机制可能与下调PI3K-AKT信号通路及上调鞘脂代谢相关。
要点
- BKG治疗8周可显著改善老年人中医衰老症状(p<0.001)。
- BKG显著降低SOD水平(p=0.046)及TNF-α水平(p=0.044)。
- 体外实验显示BKG可增加AC16细胞端粒长度并降低ROS水平(p<0.05)。
核心结论
- BKG可显著改善衰老相关症状并提高SOD水平,其作用可能与逆转多种衰老相关基因表达有关。
- PI3K-AKT信号通路与鞘脂代谢可能是BKG抗衰老的潜在机制。
研究设计与样本
- 采用自身对照研究,结合RNA-seq与代谢组学阐述BKG的疗效、安全性及调控机制。
- 体外以D-半乳糖处理AC16细胞建立衰老细胞模型进行验证。
主要发现
- 治疗8周后,BKG显著降低老年人SOD水平(p=0.046)、中医衰老症状(p<0.001)及TNF-α水平(p=0.044)。
- 高通量测序显示BKG分别逆转70个衰老相关基因和79个代谢物的表达。
- 富集分析提示BKG下调PI3K-AKT信号通路、ECM-受体相互作用及Rap1信号通路,上调鞘脂代谢。
- 体外D-半乳糖处理后AC16细胞活力和端粒长度显著下降(p<0.05)、ROS表达升高(p<0.05)。
- BKG显著增加AC16细胞端粒长度并降低ROS水平(p<0.05),且下调THBS1、PDGFRA、EPS8L1表达(p<0.05)。
关键数值与推荐
- BKG治疗8周后SOD水平变化p=0.046,中医衰老症状p<0.001,TNF-α水平p=0.044。
- 高通量测序显示BKG逆转70个衰老相关基因和79个代谢物的表达。
- 体外实验显示BKG对AC16细胞端粒长度及ROS水平的影响p<0.05,对THBS1、PDGFRA、EPS8L1表达影响p<0.05。
临床怎么用
- BKG可作为改善老年人衰老相关症状的潜在中药复方,尤其适用于中医衰老症状明显者。
- 其抗衰老作用可能与调控PI3K-AKT信号通路及鞘脂代谢有关,可作为机制研究方向。
局限性
- 研究采用自身对照设计,未设安慰剂对照,证据等级有限。
- 样本量及人群特征未在摘要中报告,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Aging is characterized by a decline in the adaptability and resistance of the body. In this study, Bushen Kangshuai Granules (BKG), as a kind of Chinese herbal formula, was developed and shown to alleviate aging-related symptoms. Methods: Self-controlled study combined with RNA-seq and metabonomics were used to expound the efficacy and safety of BKG and revealed the regulation mechanism of BKG treating aging. In vitro experiments were used to confirm the analytical results. The aging cell model of AC16 cells were treated with D-galactose. The RT-qPCR was used to detect the impact of BKG on telomere length. The DCFH-DA staining was used for detecting intracellular ROS. The targeted signaling pathway was selected and verified using Western blot. Results: After 8 weeks of treatment, BKG significantly reduced SOD level (p = 0.046), TCM aging symptoms (p < 0.001) and TNF-α level (p = 0.044) in the elderly participants. High-throughput sequencing showed that BKG reversed the expression of 70 and 79 age-related genes and metabolites, respectively. Further enrichment analysis indicated that BKG downregulated the PI3K-AKT signaling pathway, extracellular matrix (ECM)-receptor interaction, and Rap1 signaling pathway, while up-regulating sphingolipid metabolism. The results of in vitro experiments show that, after D-gal treatment, the viability and telomere length of AC16 cells significantly decreased (p < 0.05), while the expression of ROS increased (p < 0.05), BKG significantly increased the telomere length of AC16 cells and reduced the level of ROS expression (p < 0.05). In addition, BKG decreased the expression of THBS1, PDGFRA, and EPS8L1(p < 0.05), consistent with the RNA-seq results. Our results also showed that BKG affects PI3K-AKT signaling pathway. Conclusion: BKG can significantly improve aging-related symptoms and increase SOD levels, which may be associated with the reversal of the expression of various aging-related genes. The PI3K-AKT signaling pathway and sphingolipid metabolism may be potential mechanisms underlying BKG anti-aging effects.
引用
- Hu J, Yang F, Yang G, et al. Integrating transcriptomics and metabolomics to reveal the protective effect and mechanism of Bushen Kangshuai Granules on the elderly people. Front Pharmacol. 2024. PMID: 39135783. doi:10.3389/fphar.2024.1361284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。